Efficacy and safety of ixekizumab over four years of open-label treatment in a Phase 2 study in chronic plaque psoriasis

Authors
Category Primary study
ConferenceExperimental Dermatology
Year 2016
This article has no abstract
Epistemonikos ID: 00801e62e2f36a31981c65155ec88fe7ca3f89dc
First added on: Apr 29, 2026